Elotuzumab and dexamethasone for relapsed or refractory multiple myeloma patients: A retrospective study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Elotuzumab and dexamethasone for relapsed or refractory multiple myeloma patients: A retrospective study

Published:2018-04-25 Issue:6 Volume:100 Page:621-623
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Gross Zachary¹,Rahbari Ashkon¹²,Wirtschafter Eric¹³,Spektor Tanya M.⁴,Udd Kyle A.¹,Bujarski Sean¹,Ghermezi Michael¹,Nosrati Jason D.¹⁵,Vidisheva Aleksandra⁴⁶,Eades Benjamin²,Cecchi Gary⁷,Maluso Tina²,Swift Regina²,Berenson James R.¹²⁴^ORCID

Affiliation:

1. Institute for Myeloma and Bone Cancer Research; West Hollywood CA USA

2. James R Berenson, MD Inc; West Hollywood CA USA

3. Olive View-UCLA Medical Center; Sylmar CA USA

4. Oncotherapeutics; West Hollywood CA USA

5. Michigan State University College of Human Medicine; East Lansing MI USA

6. University of Arizona College of Medicine; Tucson AZ USA

7. Northern California Hematology; Berkeley CA USA

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.13058/fullpdf

Reference5 articles.

1. Strategy for the treatment of multiple myeloma utilizing monoclonal antibodies: a new era begins;Magarotto;Leuk Lymphoma,2015

2. A phase 1, multicenter, open-label, dose escalation study of elotuzumab in patients with advanced multiple myeloma;Zonder;Blood,2011

3. Elotuzumab therapy for relapsed or refractory multiple myeloma;Lonial;N Engl J Med,2015

4. A phase 2 safety study of accelerated elotuzumab infusion, over less than 1 h, in combination with lenalidomide and dexamethasone, in patients with multiple myeloma;Berenson;Am J Hematol,2017

5. Practical management of adverse events in multiple myeloma: can therapy be attenuated in older patients?;Palumbo;Blood Rev,2011

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple myeloma refractory to lenalidomide: A systematic literature review of trials and real‐world evidence;British Journal of Haematology;2024-07-19

2. Pomalidomide in relapsed and refractory multiple myeloma: multicenter retrospective study;Oncohematology;2022-07-20

3. Frequent occurrence of hypophosphatemia among multiple myeloma patients treated with elotuzumab: a single clinic retrospective study;Annals of Hematology;2020-11-25

4. Treatment With Elotuzumab in Combination With Dexamethasone Achieves a Complete Remission in a Previously Treated Patient With Multiple Myeloma: A Case Report;Clinical Lymphoma Myeloma and Leukemia;2020-11

5. Dexamethasone/elotuzumab;Reactions Weekly;2018-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3